Open Access
Volume 17, Number 4, Juillet-Août 2010
Dossier : Lipides marins
Page(s) 259 - 263
Section Prix de thèse
Published online 15 July 2010
  • Barker SA, Yap SP, Yuen KH, et al. An investigation into the structure and bioavailability of alpha-tocopherol dispersions in Gelucire 44/14. J Control Release 2003; 91: 477–488. [CrossRef] [PubMed] [Google Scholar]
  • Bernback S, Blackberg L, Hernell O. Fatty acids generated by gastric lipase promote human milk triacylglycerol digestion by pancreatic colipase-dependent lipase. Biochim Biophys Acta 1989; 1001: 286–293. [CrossRef] [PubMed] [Google Scholar]
  • Bodmer MW, Angal S, Yarranton GT, et al. Molecular cloning of a human gastric lipase and expression of the enzyme in yeast. Biochim Biophys Acta 1987; 909: 237–244. [CrossRef] [PubMed] [Google Scholar]
  • Carriere F, Barrowman JA, Verger R, et al. Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. Gastroenterology 1993; 105: 876–888. [CrossRef] [PubMed] [Google Scholar]
  • Carriere F, Moreau H, Gargouri Y, et al. Purification and biochemical characterization of dog gastric lipase. Eur J Biochem 1991; 202: 75–83. [CrossRef] [PubMed] [Google Scholar]
  • Carriere F, Renou C, Lopez V, et al. The specific activities of human digestive lipases measured from the in vivo and in vitro lipolysis of test meals. Gastroenterology 2000; 119: 949–960. [CrossRef] [PubMed] [Google Scholar]
  • Charman SA, Charman WN, Rogge MC, et al. Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res 1992; 9: 87–93. [CrossRef] [PubMed] [Google Scholar]
  • Charman WN, Porter CJ, Mithani S, et al. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci 1997; 86: 269–282. [CrossRef] [PubMed] [Google Scholar]
  • De Caro J, Sias B, Grandval P, et al. Characterization of pancreatic lipase-related protein 2 isolated from human pancreatic juice. Biochim Biophys Acta 2004; 1701: 89–99. [CrossRef] [PubMed] [Google Scholar]
  • Eaimtrakarn S, Rama Prasad YV, Ohno T, et al. Absorption enhancing effect of labrasol on the intestinal absorption of insulin in rats. J Drug Target 2002; 10: 255–260. [CrossRef] [PubMed] [Google Scholar]
  • Eydoux C, De Caro J, Ferrato F, et al. Further biochemical characterization of human pancreatic lipase-related protein 2 expressed in yeast cells. J Lipid Res 2007; 48: 1539–1549. [CrossRef] [PubMed] [Google Scholar]
  • Fernandez S, Chevrier S, Ritter N, et al. In vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self emulsifying excipients Labrasol and Gelucire 44/14. Pharm Res 2009; 26: 1901–1910. [CrossRef] [PubMed] [Google Scholar]
  • Fernandez S, Jannin V, Rodier JD, et al. Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters. Biochim Biophys Acta 2007; 1771: 633–640. [CrossRef] [PubMed] [Google Scholar]
  • Fernandez S, Rodier JD, Ritter N, et al. Lipolysis of the semi-solid self-emulsifying excipient Gelucire 44/14 by digestive lipases. Biochim Biophys Acta 2008; 1781: 367–375. [CrossRef] [PubMed] [Google Scholar]
  • Gargouri Y, Pieroni G, Rivière C, et al. Importance of human gastric lipase for intestinal lipolysis: an in vitro study. Biochim Biophys Acta 1986; 879: 419–423. [CrossRef] [PubMed] [Google Scholar]
  • Hauss DJ, Fogal SE, Ficorilli JV, et al. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci 1998; 87: 164–169. [CrossRef] [PubMed] [Google Scholar]
  • Holm R, Porter CJ, Edwards GA, et al. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur J Pharm Sci 2003; 20: 91–97. [CrossRef] [PubMed] [Google Scholar]
  • Hu Z, Tawa R, Konishi T, et al. A novel emulsifier, labrasol, enhances gastrointestinal absorption of gentamicin. Life Sci 2001; 69: 2899–2910. [CrossRef] [PubMed] [Google Scholar]
  • Pouton CW, Porter CJ. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev 2008; 60: 625–637. [CrossRef] [PubMed] [Google Scholar]
  • Rama Prasad YV, Eaimtrakarn S, Ishida M, et al. Evaluation of oral formulations of gentamicin containing labrasol in beagle dogs. Int J Pharm 2003; 268: 13–21. [CrossRef] [PubMed] [Google Scholar]
  • Rama Prasad YV, Minamimoto T, Yoshikawa Y, et al. In situ intestinal absorption studies on low molecular weight heparin in rats using labrasol as absorption enhancer. Int J Pharm 2004; 271: 225–232. [CrossRef] [PubMed] [Google Scholar]
  • Sek L, Porter CJ, Charman WN. Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis. J Pharm Biomed Anal 2001; 25: 651–661. [CrossRef] [PubMed] [Google Scholar]
  • Sek L, Porter CJ, Kaukonen AM. Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products. J Pharm Pharmacol 2002; 54: 29–41. [CrossRef] [PubMed] [Google Scholar]
  • Vaganay S, Joliff G, Bertaux O, et al. The complete cDNA sequence encoding dog gastric lipase. DNA seq 1998; 8: 257–262. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.